News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
701,107 Results
Type
Article (41599)
Company Profile (463)
Press Release (659045)
Section
Business (208397)
Career Advice (2005)
Deals (35942)
Drug Delivery (92)
Drug Development (83301)
Employer Resources (169)
FDA (16325)
Job Trends (15046)
News (352087)
Policy (32979)
Tag
Academia (2619)
Alliances (50608)
Alzheimer's disease (1273)
Approvals (16250)
Artificial intelligence (139)
Bankruptcy (361)
Best Places to Work (11733)
Biotechnology (349)
Breast cancer (124)
Cancer (1115)
Cardiovascular disease (102)
Career advice (1673)
Cell therapy (248)
Clinical research (66000)
Collaboration (408)
Compensation (199)
COVID-19 (2590)
C-suite (100)
Data (1138)
Diabetes (156)
Diagnostics (6197)
Earnings (86044)
Employer resources (147)
Events (112927)
Executive appointments (316)
FDA (16871)
Funding (366)
Gene therapy (193)
GLP-1 (611)
Government (4410)
Healthcare (18995)
Infectious disease (2675)
Inflammatory bowel disease (113)
Interviews (308)
IPO (16573)
Job creations (3695)
Job search strategy (1429)
Layoffs (439)
Legal (7928)
Lung cancer (174)
Manufacturing (181)
Medical device (13322)
Medtech (13327)
Mergers & acquisitions (19433)
Metabolic disorders (426)
Neuroscience (1564)
NextGen Class of 2024 (6733)
Non-profit (4532)
Northern California (1496)
Obesity (245)
Opinion (198)
Patents (103)
People (57629)
Phase I (20682)
Phase II (29138)
Phase III (21546)
Pipeline (459)
Postmarket research (2590)
Preclinical (8882)
Radiopharmaceuticals (252)
Rare diseases (234)
Real estate (5998)
Regulatory (21956)
Research institute (2403)
Resumes & cover letters (351)
Southern California (1324)
Startups (3747)
United States (13874)
Vaccines (565)
Weight loss (183)
Date
Today (133)
Last 7 days (804)
Last 30 days (3887)
Last 365 days (36711)
2024 (33682)
2023 (41013)
2022 (52276)
2021 (56765)
2020 (54924)
2019 (47419)
2018 (35697)
2017 (33024)
2016 (32346)
2015 (38396)
2014 (32185)
2013 (27109)
2012 (29220)
2011 (29863)
2010 (27992)
Location
Africa (731)
Arizona (200)
Asia (38512)
Australia (6402)
California (3418)
Canada (1293)
China (252)
Colorado (148)
Connecticut (162)
Europe (83995)
Florida (462)
Georgia (116)
Illinois (354)
Indiana (199)
Kansas (99)
Maryland (590)
Massachusetts (2727)
Michigan (159)
Minnesota (278)
New Jersey (970)
New York (973)
North Carolina (759)
Northern California (1496)
Ohio (141)
Pennsylvania (852)
South America (1105)
Southern California (1324)
Texas (476)
Utah (92)
Washington State (374)
701,107 Results for "xortx therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
XORTX to Present at BIO International Convention 2024
XORTX Therapeutics Inc. is pleased to announce its participation in the BIO International Convention 2024, being held June 3rd through 6th , 2024.
June 4, 2024
·
3 min read
XORTX Announces Participation in Spring 2024 Investor Conferences
XORTX Therapeutics Inc. announces that Dr. Allen Davidoff, CEO, is scheduled to participate in the following Spring 2024 investor and life sciences investment conferences.
April 8, 2024
·
2 min read
XORTX Announces Publication of Key Research in ADPKD
XORTX Therapeutics Inc. is pleased to announce a research paper titled “Raising serum uric acid with a uricase inhibitor worsens PKD in rat and mouse models” has been accepted for publication in the peer-reviewed American Journal.
April 22, 2024
·
7 min read
Press Releases
XORTX Initiates Precision Medicine Program
October 9, 2024
·
6 min read
XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical Trial
XORTX Therapeutics Inc. is pleased to provide a summary of Company’s achievements in 2023 and objectives planned for 2024.
March 19, 2024
·
6 min read
XORTX Reprices Balance of Warrants Issued in Connection with October 2021 US IPO
XORTX Therapeutics Inc. announces that further to its press releases of March 11 and April 30, 2024, the Company has received TSX Venture Exchange approval to amend the terms of the balance of outstanding common share purchase warrants that were issued on October 15, 2021.
May 17, 2024
·
3 min read
Business
XORTX Welcomes New Member to the Board of Directors - April 08, 2024
XORTX Therapeutics Inc. welcomes Abigail Jenkins, a biotech industry veteran with deep experience with the commercialization of therapies for renal and cardiovascular disease, to its Board of Directors.
April 8, 2024
·
4 min read
Press Releases
XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2024
October 25, 2024
·
6 min read
Business
XORTX Announces New Clinical Advisory Board Member - March 27, 2024
XORTX Therapeutics Inc., a biopharmaceutical company focused on developing innovative therapies to treat autosomal dominant polycystic kidney disease, is pleased to announce that Dr. Ronald Perrone has joined the Company’s Clinical Advisory Board.
March 27, 2024
·
4 min read
Press Releases
XORTX Announces Results of Annual and Special Meeting of Shareholders
September 13, 2024
·
4 min read
1 of 70,111
Next
